![MiMedx Group Inc](/common/images/company/N_MDXG.png)
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key prod... MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, MiMedx sells allografts for ophthalmic surgery and dental applications through licenses to third parties. Show more
MARIETTA, Ga., June 26, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the appointment of Kim Moller to Chief Commercial Officer. Ms...
MARIETTA, Ga., May 15, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the...
Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management to...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.29 | 4.25219941349 | 6.82 | 7.16 | 6.7 | 416190 | 6.81871461 | CS |
4 | -0.05 | -0.698324022346 | 7.16 | 7.19 | 6.59 | 630810 | 6.82069899 | CS |
12 | 0.77 | 12.1451104101 | 6.34 | 8.24 | 5.6501 | 719460 | 7.06664323 | CS |
26 | -0.94 | -11.6770186335 | 8.05 | 9.0394 | 5.6501 | 744309 | 7.47231853 | CS |
52 | 0.5 | 7.56429652042 | 6.61 | 9.27 | 5.57 | 717043 | 7.48943802 | CS |
156 | -4.49 | -38.7068965517 | 11.6 | 15.99 | 2.43 | 666638 | 6.15798436 | CS |
260 | 0.37 | 5.48961424332 | 6.74 | 15.99 | 2.43 | 696287 | 6.94955856 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.